Is Primiparity a Risk Factor for Neonatal Hyperbilirubinemia?

Completed

• Conditions: Hyperbilirubinemia, Neonatal

• Registration Number: NCT03329040
• Lead Sponsor: Hillel Yaffe Medical Center

Brief Summary

Neonatal hyperbilirubinemia elongates hospital stay and may require treatment. The investigators noticed that bilirubin levels were higher among infants of primipara mothers than among multipara mothers. As this data is dichotomic and easy to produce, and may influence the maintenance, the investigators decided to find out if primiparity is a risk factor for neonatal hyperbilirubinemia. The investigators intend to collect data from patient files during one year, and compare the bilirubin levels and length of stay between newborns to primipara mothers and multipara mothers.

Detailed Description

Neonatal hyperbilirubinemia elongates hospital stay and may require treatment. The investigators noticed that bilirubin levels were higher among infants of primipara mothers than among multipara mothers. As this data is dichotomic and easy to produce, and may influence the maintenance, the investigators decided to find out if primiparity is a risk factor for neonatal hyperbilirubinemia. The investigators intend to collect data from patient files during one year, and compare the bilirubin levels and length of stay between newborns to primipara mothers and multipara mothers.

Study Timeline

• Study First Submitted: 2017-10-30
• Study First Submitted QC: 2017-10-30
• Study First Posted: 2017-11-01
• Study Start: 2018-01-01
• Status Verified: 2018-09
• Primary Completion: 2018-09-20
• Study Completion: 2018-09-20
• Last Update Submitted: 2018-09-20
• Last Update Posted: 2018-09-21

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 4369

Inclusion Criteria

• All infants that were born during one year in a single medical center and were transferred to well baby nursery, and were discharged from the well baby nursery.

Exclusion Criteria

• Infants who were transferred to neonatal intensive care unit due to any reason.
• Infants whose mother could not take care of them (due to admission to intensive care unit, or due to adoption)

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Length of stay of the infant	2 weeks	Length of stay of the infant

Secondary Outcome Measures

Name	Time	Method
Highest bilirubin level	2 weeks	Highest bilirubin level
Age at highest bilirubin level	2 weeks	Age at highest bilirubin level

Trial Locations

Locations (1)

Hillel Yaffe medical center; 🇮🇱 H̱adera, Hadera, Israel